Led · Series C · Jul 2026

Spun out of the University of Oxford in 2017, Moa Technology operates proprietary discovery platforms that have screened over 900,000 compounds and discovered more than 80 novel mode of action areas capable of breaking weed resistance. Several of its advanced programmes are now in their third year of international field trials, and in 2025 the company disclosed a new category of non-herbicidal products called Moa Amplifiers. Moa has established R&D collaborations with major industry partners including Nufarm, Gowan, Certis Belchim and Corteva Agriscience to progress commercial applications. The company plans to use its Series C proceeds and partner payments to push three lead programmes closer to commercialisation, expand its early-stage pipeline, and continue development of the Moa Amplifiers strategy. Its platform and commercial partnerships are positioned to support further industry deals and field deployment of its discoveries.

Participated · Series B · Jul 2026

Kraken Technology develops and manufactures autonomous maritime platforms such as uncrewed subsurface vessels for military and security use. Its technology is already used by NATO, the UK Ministry of Defence and the US Navy, and it counts US defence firm Anduril as a partner. Founded in 2020, the British-founded startup has expanded into manufacturing and operational deployment for defence customers. The company said it will use the new funding to develop an uncrewed surface vessel and to expand manufacturing facilities. Financially, Kraken achieved unicorn status with a $175 million Series B at a $1 billion valuation.

Led · Series A · Apr 2026

HEPTA Medical develops a device that integrates a minimally invasive thermal ablation probe introduced via natural orifices to destroy early lung tumors by heat. The company highlights a large unmet need given more than 2.2 million new lung cancer cases and roughly 1.8 million deaths annually worldwide. Founded in 2019 and based in Suresnes, HEPTA employs around a dozen people. Financially, it has just closed a €10 million Series A to fund growth and hiring. The startup plans to initiate its first clinical trials in the second quarter of 2026. Its investor base includes UI Investissement and Supernova Invest as new participants alongside Bpifrance, M & L, Sofinnova Partners, Cléry and MD Start.

Led · Series A · Mar 2026

Heliup focuses on speeding up the roll-out of photovoltaic modules, aiming to expand solar energy adoption. The company’s core offering centers on technologies and services that streamline the installation and deployment of solar panels. With fresh financing, Heliup plans to scale its operations and increase the volume of photovoltaic modules it can deliver to market. Although the article does not disclose operating metrics such as revenue or installation figures, the new capital signals investor confidence in the firm’s growth prospects. Future initiatives will likely emphasize larger deployment projects and continued product refinement to improve efficiency in solar installations. No additional financial details—such as prior funding totals, revenue, or profitability—were provided in the reporting.

Led · Equity · Feb 2026

ISYBOT is a robotics startup headquartered in Les Ulis (Essonne) that designs and manufactures collaborative robots, or cobots, specifically tailored for sanding and grinding tasks on factory floors. Its machines are intended to work safely alongside human operators, improving productivity on labor-intensive surface-finishing jobs. After an unsuccessful fundraising effort in autumn 2024 led to court-supervised restructuring in February 2025, the company negotiated a ten-year debt repayment plan and emerged from receivership. Backed by deep-tech investors Bpifrance and Supernova Invest, ISYBOT has now secured fresh capital to restart growth. Management plans to expand into additional European markets and scale up production capacity. The €7 million infusion provides the working capital needed to fulfill these expansion and manufacturing goals.